Scholarly article on tri-O-benzoyl-DL-threonic acid amide 3255-72-9 from Journal of the American Chemical Society p. 1091,1094

DOI: 10.1021/ja01235a009

Source and publish data:

Journal of the American Chemical Society p. 1091,1094 (1944)

Update date:2022-07-29

Topics:

Authors:

Lake Lake

Glattfeld

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/ja01235a009

Full text of DOI:10.1021/ja01235a009

Products guided by the article

Product name:tri-O-benzoyl-DL-threonic acid amide

Cas No:3255-72-9

R&D Labs maybe for 3255-72-9

Liaoyang Xinyou Chemical Products Co.,Ltd.

Contact:+86-419-5165433 13604191870

Address:Huishang Road6-1, Hongwei District, Liaoyang, Liaoning, China
Guangzhou Probig Fine Chemical Co., Ltd.

Contact:020-86297874

Address:No.2, 1/F, No.20, Hetai Road,Hebian Village, Baiyun District,Guangzhou,China
Quzhou Ruiyuan chemical Co., Ltd

Contact:+86-570-3039321/3039361/3039308

Address:18# Huayang Road,Quzhou High-tech Industrial Park, Zhejiang China.
Shanghai ZaiQi Bio-Tech Co., Ltd.,

Contact:+86-21-5482 4098

Address:Bldg. No.7, No.201 MinYi Rd，Songjiang CaoHeJing High-Tech Park Shanghai 201516 P,R,China
Sichuan Highlight Fine Chemicals Co., Ltd.

Contact:+86-28-8525 1605

Address:A5-102 Airport base,388 West Airport Huang He Zhong Lu,2 Section

Relevant to this article

The convenient Michael addition of imidazoles to acrylates catalyzed by Lipozyme TL im from: Thermomyces lanuginosus in a continuous flow microreactor

Doi:10.1039/c8ob02533a
(2019)
Doi:10.1021/jm00288a018
(1971)
Total synthesis of (+)-crocacin C

Doi:10.1016/S0040-4020(01)00940-1
(2001)
New synthetic strategy for chiral 2-oxazolidinones derivatives via rhodium-catalyzed asymmetric hydrogenation

Doi:10.1016/j.tetlet.2015.12.105
(2016)
Synthesis of analogs of the ergot alkaloids

Doi:10.1002/jhet.5570370614
(2000)
Discovery of 1-(4-(4-Amino-3-(4-(2-morpholinoethoxy)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)phenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea (CHMFL-FLT3-213) as a Highly Potent Type II FLT3 Kinase Inhibitor Capable of Overcoming a Variety of FLT3 Kinase Mutan

Doi:10.1021/acs.jmedchem.7b00840
(2017)

Article Doi

DOI: 10.1021/ja01235a009